RGD Reference Report - Correction of diabetic erectile dysfunction with adipose derived stem cells modified with the vascular endothelial growth factor gene in a rodent diabetic model. - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

Correction of diabetic erectile dysfunction with adipose derived stem cells modified with the vascular endothelial growth factor gene in a rodent diabetic model.

Authors: Liu, G  Sun, X  Bian, J  Wu, R  Guan, X  Ouyang, B  Huang, Y  Xiao, H  Luo, D  Atala, A  Zhang, Y  Deng, C 
Citation: Liu G, etal., PLoS One. 2013 Aug 30;8(8):e72790. doi: 10.1371/journal.pone.0072790.
RGD ID: 7364777
Pubmed: PMID:24023647   (View Abstract at PubMed)
PMCID: PMC3758339   (View Article at PubMed Central)
DOI: DOI:10.1371/journal.pone.0072790   (Journal Full-text)

The aim of this study was to determine whether adipose derived stem cells (ADSCs) expressing vascular endothelial growth factor (VEGF) gene can improve endothelial function, recover the impaired VEGF signaling pathway and enhance smooth muscle contents in a rat diabetic erectile dysfunction (DED) model. DED rats were induced via intraperitoneal injection of streptozotocin (40 mg/kg), and then screened by apomorphine (100 microg/kg). Five groups were used (n = 12/group)-Group 1 (G1): intracavernous injection of lentivirus-VEGF; G2: ADSCs injection; G3: VEGF-expressing ADSCs injection; G4: Phosphate buffered saline injection; G1-G4 were DED rats; G5: normal rats. The mean arterial pressure (MAP) and intracavernosal pressure (ICP) were measured at days 7 and 28 after the injections. The components of the VEGF system, endothelial, smooth muscle, pericytes markers in cavernoursal tissue were assessed. On day 28 after injection, the group with intracavernosum injection of ADSCs expressing VEGF displayed more efficiently and significantly raised ICP and ICP/MAP (p<0.01) than those with ADSCs or lentivirus-VEGF injection. Western blot and immunofluorescent analysis demonstrated that improved erectile function by ADSCs-VEGF was associated with increased expression of endothelial markers (VEGF, VEGF R1, VEGF R2, eNOS, CD31 and vWF), smooth muscle markers (a-actin and smoothelin), and pericyte markers (CD146 and NG2). ADSCs expressing VEGF produced a therapeutic effect and restored erectile function in diabetic rats by enhancing VEGF-stimulated endothelial function and increasing the contents of smooth muscle and pericytes.

RGD Manual Disease Annotations    Click to see Annotation Detail View
TermQualifierEvidenceWithReferenceNotesSourceOriginal Reference(s)
impotence  ISOMcam (Rattus norvegicus)7364777; 7364777protein:decreased expression:penis erectile tissueRGD 
impotence  IEP 7364777protein:decreased expression:penis erectile tissueRGD 

Objects Annotated

Genes (Rattus norvegicus)
Mcam  (melanoma cell adhesion molecule)

Genes (Mus musculus)
Mcam  (melanoma cell adhesion molecule)

Genes (Homo sapiens)
MCAM  (melanoma cell adhesion molecule)


Additional Information